强生与JJDc达成协议 MeiraGTx股票锁定期延长12个月

美股速递
Apr 16

根据美国证券交易委员会最新披露的文件显示,强生公司及其子公司JJDc已与基因疗法公司MeiraGTx Holdings Plc达成重要协议。双方约定在交易完成后的12个月内,对持有的MeiraGTx股票实施锁定期限制。

这一锁定安排意味着相关方在此期间不得出售或转让其持有的MeiraGTx股份。该举措通常被视为对公司长期发展前景的信心表现,有助于维护股价稳定和市场信心。

作为基因治疗领域的知名企业,MeiraGTx专注于开发针对严重疾病的新型疗法。此次锁定期协议的达成,标志着合作双方战略伙伴关系的进一步深化。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10